Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralising Antibody Fab Fragment

Journal of Molecular Biology

Volumn 384, Issue 5, 2008, Pages 1203-1217

  Leonard, Philip ^a   Scotney, Pierre D ^b   Jabeen, Talat ^a   Iyer, Shalini ^a   Fabri, Louis J ^b   Nash, Andrew D ^b   Acharya, K Ravi ^a  

^a University of Bath   (United Kingdom)

^b CSL LIMITED   (Australia)

Author keywords

angiogenesis; neutralising antibody; VEGF B; VEGF B Fab complex; X ray crystallography

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN F(AB) FRAGMENT; VASCULOTROPIN B;

ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; STEREOSPECIFICITY;

EID: 56949090144     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.09.076     Document Type: Article

References (49)

1. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res. 55 (2000) 15-35
2. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl Acad. Sci. USA 93 (1996) 2576-2581
3. Bellomo D., Headrick J.P., Silins G.U., Paterson C.A., Thomas P.S., Gartside M., et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ. Res. 86 (2000) E29-E35
4. Li X., Tjwa M., van Hove I., Enholm B., Neven E., Paavonen K., et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularisation of the ischemic myocardium. Arterioscler. Thromb. Vasc. Biol. (2008) published online on May 29
5. Li X., Aase K., Li H., von Euler G., and Eriksson U. Isoform-specific expression of VEGF-B in normal tissues and tumors. Growth Factors 19 (2001) 49-59
6. Gunningham S.P., Currie M.J., Han C., Robinson B.A., Scott P.A., Harris A.L., and Fox S.B. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J. Pathol. 193 (2001) 325-332
7. Louzier V., Raffestin B., Leroux A., Branellec D., Caillaud J.M., and Levame M. Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 284 (2003) 926-937
8. Scotney P.D., MacKenzie A., Maccarone P., Fabri L.J., Scrofani S.D., Gooley P.R., and Nash A.D. Human vascular endothelial growth factor B: characterization of recombinant isoforms and generation of neutralizing monoclonal antibodies. Clin. Exp. Pharmacol. Physiol. 29 (2002) 1024-1029
9. Iyer S., Scotney P.D., Nash A.D., and Acharya K.R. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding. J. Mol. Biol. 359 (2006) 76-85
10. Wiesmann C., Fuh G., Christinger H.W., Eigenbrot C., Wells J.A., and de Vos A.M. Crystal structure at 1.7 Å resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91 (1997) 695-704
11. Christinger H.W., Fuh G., de Vos A.M., and Wiesmann C. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J. Biol. Chem. 279 (2004) 10382-10388
12. Derrick J.P., and Wigley D.B. The third IgG-binding domain from streptococcal protein G. An analysis by X-ray crystallography of the structure alone and in a complex with Fab. J. Mol. Biol. 243 (1994) 906-918
13. DeLano W.L. PyMOL Molecular Graphics System (2002). http://www.pymol.org http://www.pymol.org
14. Chothia C., and Lesk A.M. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196 (1987) 901-917
15. Ramachandran G.N., and Sasisekharan V. Conformation of polypeptides and proteins. Adv. Protein Chem. 23 (1968) 283-438
16. Laskowski R.A., Moss D.S., and Thornton J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231 (1993) 1049-1067
17. -108 complex. J. Mol. Biol. 273 (1997) 882-897
18. Muller Y.A., Chen Y., Christinger H.W., Li B., Cunningham B.C., Lowman H.B., and de Vos A.M. VEGF and the Fab fragment of a humanised neutralising antibody: crystal structure of the complex at 2.4 Å resolution and mutational analysis of the interface. Structure 6 (1998) 1153-1167
19. Chen Y., Wiesmann C., Fuh G., Li B., Christinger H.W., McKay P., et al. Selection and analysis of an optimised anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J. Mol. Biol. 293 (1999) 865-881
20. Keitel T., Kramer A., Wessner H., Scholz C., Schneider-Mergener J., and Hohne W. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 91 (1997) 811-820
21. McDonald I.K., and Thornton J.M. Satisfying hydrogen bonding potentials in proteins. J. Mol. Biol. 238 (1994) 777-793
22. Collaborative Computational Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. Sect. D 50 (1994) 760-763
23. Stanfield R.L., Zemla A., Wilson I.A., and Rupp B. Antibody elbow angles are influenced by their light chain class. J. Mol. Biol. 357 (2006) 1566-1574
24. Wilson I.A., and Stanfield R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4 (1994) 857-867
25. Chothia C., Lesk A.M., Tramontano A., Levitt M., Smith-Gill S.J., Air G., et al. Conformations of immunoglobulin hypervariable regions. Nature 342 (1989) 877-883
26. Al-Lazikani B., Lesk A.M., and Chothia C. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273 (1997) 927-948
27. Morea V., Tramontano A., Rustici M., Chothia C., and Lesk A.M. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol. 275 (1998) 269-294
28. Davies D.R., and Cohen G.H. Interactions of protein antigens with antibodies. Proc. Natl Acad. Sci. USA 93 (1996) 7-12
29. Chavali G.B., Papageorgiou A.C., Olson K.A., Fett J.W., Hu G., Shapiro R., and Acharya K.R. The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody. Structure 11 (2003) 875-885
30. Fellouse F.A., Wiesmann C., and Sidhu S.S. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc. Natl Acad. Sci. USA 101 (2004) 12467-12472
31. Fuh G., Wu P., Liang W.C., Ultsch M., Lee C.V., Moffat B., and Wiesmann C. Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab. J. Biol. Chem. 281 (2006) 6625-6631
32. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis 18 (1997) 2714-2723
33. Fellouse F.A., Barthelemy P.A., Kelley R.F., and Sidhu S.S. Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J. Mol. Biol. 357 (2006) 100-114
34. Olofsson B., Korpelainen E., Pepper M.S., Mandriota S.J., Aase K., Kumar V., et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl Acad. Sci. USA 95 (1998) 11709-11714
35. Kabbinavar F., Hurwitz H.I., Fehrenbacher L., Meropol N.J., Novotny W.F., and Lieberman G. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J. Clin. Oncol. 21 (2003) 60-65
36. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., and Kim R.Y. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355 (2006) 1419-1431
37. Yang J.C., Haworth L., Sherry R.M., Hwu P., Schwartzentruber D.J., Topalian S.L., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349 (2003) 427-434
38. Mould A.W., Tonks I.D., Cahill M.M., Pettit A.R., Thomas R., Hayward N.K., and Kay G.F. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum. 48 (2003) 2660-2669
39. Kawakami M., Furuhata T., Kimura Y., Yamaguchi K., Hata F., Sasaki K., and Hirata K. Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer. J. Exp. Clin. Cancer Res. 22 (2003) 229-237
40. Scrofani S.D., Fabri L.J., Xu P., Maccarone P., and Nash A.D. Purification and refolding of vascular endothelial growth factor-B. Protein Sci. 9 (2000) 2018-2025
41. Mould A.W., Greco S.A., Cahill M.M., Tonks I.D., Bellomo D., Patterson C., et al. Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro. Circ. Res. 97 (2005) 60-70
42. Mage M.G. Preparation of Fab fragments from IgGs of different animal species. Methods Enzymol. 70 (1980) 142-150
43. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter Jr. C.W., and Sweet R.M. (Eds). Methods in Enzymology. Macromolecular Crystallography, Part A vol. 276 (1997), Academic Press, New York 307-326
44. Read R.J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. Sect. D 57 (2001) 1373-1382
45. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D 53 (1997) 240-255
46. Emsley P., and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60 (2004) 2126-2132
47. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. Sect. D 54 (1998) 905-921
48. Makinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., et al. Inhibition of lymphangiogenesis with resulting lymph edema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7 (2001) 199-205
49. Williams T., and Kelley C. Gnuplot, An Interactive Plotting Program, Version 4.2 (2008). http://www.gnuplot.info http://www.gnuplot.info